ClinicaliQ Trial Snapshot
- Post-Market Celect Platinum Vena Cava Filter and Gunther Tulip Retrieval Set Study — Recruiting • Cardiology / Cardiovascular • NCT05881798.
- What is being tested: Real-world safety and performance data collection for two vena cava filter devices—the Celect Platinum Filter Sets and the Günther Tulip Retrieval Set—in post-market clinical practice to confirm ongoing device safety and effectiveness.
- Patient eligibility overview: This prospective, observational study enrolls patients requiring vena cava filter placement for venous thromboembolism prevention, with data collected from those who receive either of the two specified filter devices during routine clinical care.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
This prospective, observational, post-market study will be performed to collect patient-level data on the Celect Platinum Vena Cava Filter Sets and the Günther Tulip Vena Cava Filter Retrieval Set to confirm continued safety and performance of the devices throughout their expected lifetime and continued acceptability of the benefit:risk ratio. Additionally, the study intends to evaluate longer-term (i.e., up to 5 years) outcome data while the filter is indwelling.
Eligibility Snapshot
- : * A patient dataset is deemed suitable for inclusion if the patient has a procedure where a Celect Platinum Vena Cava Filter is placed * Subject has not previously participated in the Cook MDR-2126 study.
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.